These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7831686)
1. Dissociation of antithrombotic and thrombocytopenic effects of D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone in rabbits. Dundore RL; Clas DM; VanAller GS; Habeeb PG; Pagani ED Thromb Res; 1994 Sep; 75(6):663-6. PubMed ID: 7831686 [No Abstract] [Full Text] [Related]
2. Agglutination of rabbit platelets in plasma by the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Packham MA; Bryant NL; Guccione MA Thromb Haemost; 1990 Apr; 63(2):282-5. PubMed ID: 2363129 [TBL] [Abstract][Full Text] [Related]
3. The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels. Yamashita T; Yamamoto J; Sasaki Y; Matsuoka A Thromb Res; 1993 Jan; 69(1):93-100. PubMed ID: 8465278 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis. Sinha U; Ku P; Malinowski J; Zhu BY; Scarborough RM; Marlowe CK; Wong PW; Lin PH; Hollenbach SJ Eur J Pharmacol; 2000 Apr; 395(1):51-9. PubMed ID: 10781674 [TBL] [Abstract][Full Text] [Related]
5. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Hanson SR; Harker LA Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of prothrombinase and thrombin inhibitors in a novel rabbit model of non-occlusive deep vein thrombosis. Hollenbach S; Sinha U; Lin PH; Needham K; Frey L; Hancock T; Wong A; Wolf D Thromb Haemost; 1994 Mar; 71(3):357-62. PubMed ID: 8029801 [TBL] [Abstract][Full Text] [Related]
7. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature. Liu JT; Paul W; Emerson M; Cicala C; Page CP Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481 [TBL] [Abstract][Full Text] [Related]
9. Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles. Wilson AJ; Zhou Q; Vargas I; Palekar R; Grabau R; Pan H; Wickline SA Methods Mol Biol; 2020; 2118():111-120. PubMed ID: 32152974 [TBL] [Abstract][Full Text] [Related]
10. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models. Palekar RU; Vemuri C; Marsh JN; Arif B; Wickline SA J Vasc Surg; 2016 Nov; 64(5):1459-1467. PubMed ID: 26482989 [TBL] [Abstract][Full Text] [Related]
11. Effects of alcohol withdrawal on responses of platelets from alcoholics--a study using platelet-rich plasma from blood anticoagulated with D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (FPRCH2Cl). Rand ML; Neiman J; Jakowec DM; Packham MA Thromb Haemost; 1990 Apr; 63(2):178-82. PubMed ID: 2363118 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047 [TBL] [Abstract][Full Text] [Related]
14. The good, the bad and the obvious: 1993 Clemson Award for Basic Research--Keynote Lecture. Sefton MV Biomaterials; 1993 Dec; 14(15):1127-34. PubMed ID: 8130316 [No Abstract] [Full Text] [Related]
15. Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin. Krpski WC; Bass A; Kelly AB; Marzec UM; Hanson SR; Harker LA Circulation; 1990 Aug; 82(2):570-7. PubMed ID: 2372903 [TBL] [Abstract][Full Text] [Related]
16. Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood. Wagner WR; Hubbell JA J Lab Clin Med; 1990 Nov; 116(5):636-50. PubMed ID: 2104522 [TBL] [Abstract][Full Text] [Related]
17. The effect of thrombin inhibition in a rat arterial thrombosis model. Broersma RJ; Kutcher LW; Heminger EF Thromb Res; 1991 Nov; 64(4):405-12. PubMed ID: 1788827 [TBL] [Abstract][Full Text] [Related]
18. Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin. Kelly AB; Hanson SR; Henderson LW; Harker LA J Lab Clin Med; 1989 Oct; 114(4):411-8. PubMed ID: 2794754 [TBL] [Abstract][Full Text] [Related]
19. Thrombin inhibition compared with other antithrombotic drugs in rats. Schumacher WA; Heran CH; Steinbacher TE; Megill JR; Bird JE; Giancarli MR; Durham SK Thromb Res; 1992 Oct; 68(2):157-66. PubMed ID: 1475778 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) as anticoagulants for critical care clinical chemistry specimens. Lyon ME; Drobot DW; Harding SR; Lyon AW Clin Chim Acta; 1999 Feb; 280(1-2):91-9. PubMed ID: 10090527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]